CinCor Pharma to Participate at Upcoming September Investor Conferences
CinCor Pharma announced participation in major investor conferences including Citi's 17th Annual BioPharma Conference from September 6-8, 2022, in Boston, MA, and Morgan Stanley’s 20th Annual Healthcare Conference on September 12-13, 2022, in New York, NY.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
CinCor Pharma announced participation in major investor conferences including Citi's 17th Annual BioPharma Conference from September 6-8, 2022, in Boston, MA, and Morgan Stanley’s 20th Annual Healthcare Conference on September 12-13, 2022, in New York, NY.
Additionally, management will present at the 2022 Wells Fargo Healthcare Conference on September 7, 2022, at 3:45 PM ET, with a live webcast available. Investors can arrange meetings during these events.
CinCor, established in 2018, focuses on innovative treatments for cardio-renal diseases, with lead drug baxdrostat in clinical development.
Details
News Market Reaction – CINC
The recorded move for CINC in the trading session of this news was +6.73%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
WALTHAM, Mass., Aug. 31, 2022 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (NASDAQ: CINC) today announced that company management will participate at the following investor conferences: Citi's 17th Annual BioPharma Conference taking place September 6 - 8, 2022 in Boston, MA and Morgan Stanley’s 20th Annual Healthcare Conference, taking place September 12 - 13, 2022 in New York, NY.
Company management will also present at the 2022 Wells Fargo Healthcare Conference on Wednesday, September 7, 2022 at 3:45 PM ET in Boston, MA. A link to the live webcast will be available at webcast/wellsfargo. An archived replay of the presentation will be available for 90 days at CinCor.com/events.
The CinCor management team will participate in investor meetings during each of these events. Investors interested in meeting with CinCor at the conference should contact their respective event representative.
About CinCor
CinCor, founded in 2018, is a clinical-stage biopharmaceutical company with a mission to bring innovation to the pharmaceutical treatment of cardio-renal diseases. Its lead asset, baxdrostat, a highly selective, oral small molecule inhibitor of aldosterone synthase, is in clinical development for the treatment of hypertension and primary aldosteronism.
| Contacts: | Investors: |
| Terry Coelho | Bob Yedid |
| CinCor Pharma, Inc. | LifeSci Advisors |
| EVP, CFO and CBDO | ir@CinCor.com |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.